MedTrace Logo

Bingo Drug-eluting Balloon in Bifurcation

NCT02325817 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 222

Last updated 2017-08-25

No results posted yet for this study

Summary

The purpose is to observe and evaluate the safety and efficacy of Bingo drug-eluting balloon in the treatment of patients with bifurcation lesions of coronary artery.

Conditions

  • Bifurcation Lesions
  • Drug Eluting Balloon

Interventions

DEVICE

Drug-eluting balloon

Treat the side branch of bifurcation lesion with drug-eluting balloon

DEVICE

Uncoated ballloon

Treat the side branch of bifurcation lesion with uncoated balloon

Sponsors & Collaborators

  • Yinyi(Liaoning) Biotech Co., Ltd.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-12-03
Primary Completion
2016-11-29
Completion
2017-01-13

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02325817 on ClinicalTrials.gov